Summary
lpr mice showed markedly reduced proteinuria and minireal glomemlar proliferation when treated orally with L-N G monomethyl arginine (L-NMMA), an inhibitor of nitric oxide synthase (NOS) (5) . These data therefore strongly suggest that nitric oxide (NO) is an important mediator of the disease manifestation of MRL/lpr mice. However, the mechanism(s) for this exaggerated NO synthesis by MRL/ lpr mice remains obscure.
NO is a critical mediator of a variety of biological functions, including vascular relaxation, platelet aggregation, neurotransmission, tumoricidal and microbicidal activity, and immunosuppression (6) (7) (8) (9) (10) . It is also implicated in a range of immunopathologies (11) (12) (13) . NO is derived from the guanidino nitrogen atom(s) (14) and molecular oxygen (15, 16) in a reaction catalyzed by the enzyme NOS. There are three major isoforms of NOS (17) : the neuronal form (nNOS) and the endothelial form (eNOS) produce the amounts of NO required for physiological functions. The cytokine-inducible form (iNOS) is induced by a number of immunological stimuli, such as IFN-% TNF-~x, and LPS, and catalyzes the high output of NO which can be cytotoxic.
Since the expression and functional activities of IFN-y and TNF-or in SLE and its animal models are highly variable and controversial (18, 19) , we explored the possibility that the exaggerated NO synthesis in MP, L/lpr mice may be due to enhanced production of other factor(s). We report here that spleen and peritoneal cells from MILL/Ipr mice produced significantly higher concentrations of lL-12 than those from the control MP, L/+, or BALB/c mice when stimulated with LPS and IFN-'y in vitro. IL-12 and LPS synergistically stimulated the spleen and peritoneal cells from MILL/lpr mice, but not from the control MR.L/+ mice, to produce high levels of NO. Furthermore, young M1LL/Ipr mice developed accelerated glomerulonephritis when injected with rlL-12 compared with control injected with PBS alone. Thus, the enhanced capacity to produce IL-12 and the higher responsiveness to IL-12/LPS to produce NO may play an important role in the pathogenesis of MRL/Ipr mice.
Materials and Methods
Mice. Female MILL/Ipr and age-and sex-matched control MRL/MP-+/+, BALB/c, and CBA/6J mice were obtained from Harlan Olac Ltd. (Bicester, UK). Some of the mice were bred in the animal facilities, University of Glasgow, from pairs obtained from Harlan Olac. They were housed in a conventional animal facility.
Cytokines and Reagents. Murine rlFN-"/was a kind gift of Dr.
G. Adolf (Bender, Vienna, Austria). Murine rlL-12 and monoclonal (clones C15.6 and C15.1.2) and polyclonal (sheep no. 7) anti-IL-12 antibodies were generously provided by Dr. Stan Wolf (Genetic Institute, Boston, MA). Polyclonal anti-IL-12, anti-IFN-y, and anti-TNF-oe antibodies were raised in rabbits immunized with murine rlL-12, rlFN-y, or TNF-cx, respectively using a standard protocol. Monodonal anti-CD4 (YTS191) and anti-CD8 (YTS169) were kindly provided by Dr Mouse Peritoneal and Spleen Cell Preparation. Peritoneal cells were collected by injecting 5-7 ml of ice-cold PBS into the peritoneal cavity before harvesting and kept on ice before use. Spleen was then removed and a single cell suspension prepared by gently forcing the spleen through a sterile tea strainer into a petri dish in HBSS (Gibco, Paisley, UK) containing 1% FCS. The cells were then washed in serum-free HBSS and viability determined by trypan blue exclusion.
Cell Depletion. Single cell suspensions (107 cells/m]) in PBS
were incubated on ice for 30 min with anti-CD4, anti-CD8 (hybridoma culture supernatant, 1:1 dilution), anti-NK (5E6, 5 p.g/ nal), anti-Thyl.2 (ascites, 1:500 dilution) or anti-Thyl.2, plus anti-NK. After 2 washes with ice-cold PBS, the cells were incubated with or without rabbit complement (1:20) in 96-well culture plates for 45 min at 37~ at 2 X 10 s cells/well in 100 p.1 of cornplete culture medium (P, PMI 1640; Gibco) supplemented with 10% heat-inactivated FCS, 50 U/ml penicillin, 50 p-g/ml streptomycin, and 50 ~M 2-mercaptoethanol). Cells were then pelleted by centrifugation of the plate and the supernatant was carefully removed. The incubation was repeated with fresh complement and followed by two washes with warm medium. Samples of the residual cells were phenotyped in parallel tubes by flow cytometry (Becton Dickinson & Co.) using FITC-or PE-conjugated antibodies to CD4, CD8 (13ecton Dickinson & Co., Oxford, UK) and CD3 (PharMingen).
Ceil Culture. Spleen (2 • 105 viable cells/well) or resident peritoneal cells (1.5-3 • 105 cells/well, varied between different experiments) in 200 p-1 were cultured in full medium in 96-well plates (Nunc, Roskilde, Denmark) at 37~ and 5% CO2 for up to 6 d. To stimulate for NO synthesis, graded doses of IL-12 and LPS were titrated and optimal doses determined. IFN-y was used at 50 U/ml unless indicated otherwise. To stimulate for IL-12 production, graded doses of LPS were titrated with 50 U/ml of IFN-',/. In the antibody neutralization experiments, cells were preincubated with specific antibodies to murine IL-12 (sheep no. 7 or rabbit anti-IL-12), IFN-% or TNF-ot for 30 rain at 37~ before the addition of stimulators. Concentrations of antibody used were supraoptimal for neutralizing the amounts of cytokines likely to be produced as determined in preliminary experiments.
CytokineAssays. IL-12 concentration was determined by an ELISA method using a combination of two rat monoclonal antibodies (C15.1.2 and C15.6, Genetic Institute) to mouse IL-12 (p40 chain) as capture antibodies, and a sheep anti-mouse IL-12 antibody (sheep no. 7) or a rabbit anti-mouse IL-12 (Rab.74.6) as detecting antibody. ELISA in 96-well plates (Immulon 4; Dynatech, Billingshurst, UK) was developed with a biotin-conjugated donkey anti-sheep IgG antibody (Sigma) followed by StrepAvidin-horseradish peroxidase (HRP) or a H1kP-conjugated donkey anti-rabbit IgG (SAPU, Carluke, UK) accordingly, TMB HRP substrate (KPL Laboratories, Gaithersburg, MD); optical density was read on a Dynatech MR5000 ELISA reader at 630 nm. Recombinant murine IL-12 (Genetic Institute) was used as standard. Normal donkey serum (2%) was used as blocker. IL-12 production was also determined by Western blot. Peritoneal cells from four 13-wk-old MP,.L/Ipr mice were pooled and cultured at 2.5
• 105 cells/ml in 25-cm 2 flasks in the presence or absence of IFN-y (50 U/ml) and LPS (i p.g/m]). Culture supernatant was harvested at 6, 12, 24, and 48 h, 3-ml samples were immune precipitated with rat monoclonal anti-IL-12 antibodies (clones C 15.1.2, and C15.6, both against the p40 chain oflL-12), and the immune complexes were captured by protein A-Sepharose beads. The precipitate was then resolved on 10% SDS-PAGE and transferred to nitrocellulose membranes (Bio-Rad, Herts, UK). After blocking with Tris-buffered saline containing 0.1% Tween 20 and 2% BSA, the membrane was incubated sequentially with anti-IL-12 antibody (sheep no. 7), biotin-conjugated donkey anti-sheep IgG, and HRP-conjugated avidin, and protein bands visualized by the enhanced chemiluminescence (ECL) system (Amersham Biosciences, Amersham, Bucks, UK). Recombinant murine IL-12 was run in parallel with the test samples.
The IFN-2t concentration was also determined by ELISA using a rat monoclonal antibody (R46AT) and a rabbit anti-mouse IFN-~/antibody. The assay was developed with an alkaline phos- assay was also used to enumerate the number of IFN-~/--secreting cells. This was carried out as described previously (20) .
Assays for NO Production. Total nitrate and nitrite concentration in serum was determined by the conversion of nitrate into nitrite as described previously (21) . Briefly, serum samples (30 p~l) were incubated with an equal volume of reaction buffer containing nicotinamide adenine dinucleotide phosphate (1 mg/ml), ravin adenine dinucleotide (8.3 mg/ml), KH2PO 4 (0.1 M), and nitrate reductase (0.7 mg/ml; Sigma), added immediately before use. Conversion was carried out at 37~ for 2 h in a 96-well ELISA plate (Immulon 2; Dynatech). Total nitrite content was then measured in a chemiluminescence NO analyzer (Dabisi model 2107; Quantitech Ltd., Milton Keynes, UK) according to the manufacturer's instruction. Nitrate standard was run in parallel with test samples. The assay was performed in triplicate and had a detection limit of 5 p~M. Nitrite concentration in culture supernatants was determined in triplicate by the Greiss reaction (22), using NaNO2 as standard with a detection limit of 1 b~M.
Detection of Serum Autoantibodies by ELISA.
This was carried out as described previously (23) using single (ss) or double (ds) stranded calf thymus DNA (Sigma) as target antigens, Pooled serum from 20-wk-old MRL/lpr mice of known high titer of anti-DNA antibodies was used as standard serum. One titration unit was arbitrarily defined as the amount of antibody present in a fixed dilution of the standard serum (1/10,000 for anti-ssDNA and 1/1,000 for anti-dsDNA antibodies).
Renal Histology. Mouse kidney tissues were fixed in formalin and embedded in paraffin; 5-p~m sections were stained with periodic acid-Schiff. For histological examination by light microscopy, sections were randomly labeled and examined blind twice by two investigators. The severity of kidney pathology was assessed by the extent of enlargement of glomeruli and mesangial cell proliferation, tuft-to-capsule adhesions, protein casts in tubules, interstitial cellular infiltration, and vasculitis. 
Results

MRL/lpr Mice Produced Higher Concentrations of NO Metabolites than Normal Mice. Serum from MRL/Ipr, MRs +,
BALB/c, and CBA mice of various ages were analyzed for N O metabolites by converting nitrate to nitrite and then determining the total nitrite content. Serum from MRL/Ipr mice consistently contained significantly higher concentrations of nitrate and nitrite than those from age-and sexmatched M R . L / + , BALB/c, or CBA/6J mice (Fig. 1 a) . There was no significant difference between the concentrations of N O metabolites produced by M R L / + , BALB/c, or CBA mice. These results therefore confirm previous findings (5) that MRL/lpr mice produce exaggerated levels of
To analyze the mechanism(s) for the exaggerated pro- (Fig. 2) . IL-12 production by the cells of MRL/lpr mice was LPS dose-and time-dependent, reaching a plateau level after 12 h (Fig. 2, b and c) . LPS or IFN-~/alone induced minimum amounts of IL-12 synthesis. Similar results were obtained with spleen cells, except that the levels of IL-12 produced were lower (data not shown). (Fig. 3, a-c) . Nitrite was detectable in the culture supernatant after 2 d and continued to increase up to day 6 (Fig. 3 a) . NO production was both IL-12 and LPS dependent (Fig. 3, b and c) . High concentrations of nitrite were also detected in cultures of peritoneal cells from MRL/Ipr mice (Fig. 3, d and e) . NO production in the present system is dependent on the adherent cell population (>90% macrophages) and barely detectable in the nonadherent cell population. However, removal of nonadherent cells significantly reduced (by 70-82%) the IL-12-induced NO production (Fig. 3 J~. This suggests that the IL-12-driven NO synthesis was via its effect on nonadherent cells.
Spleen and Peritoneal Cells from MRL/Ipr Mice Produce High
Since IFN-',/ and IL-12 are known to induce each other's synthesis, we then determined whether the en- dependent. Spleen and peritoneal cells were stimulated with IFN-~/ and LPS as above in the presence of a rabbit anti-IL-12 antiserum. The production of NO by these cells was markedly inhibited by the antiserum but not by the control preimmune serum (Fig. 4) . The inhibition was incomplete. This was because IFN-y and LPS can be expected to directly activate macrophages to produce NO. The ability of an anti-IL-12 antibody to inhibit NO synthesis also indicated that the IL-12 detected by ELISA in the culture supernatants of cells activated with IFN-',//LPS (e.g., Fig. 2 ) was not due to the IL-12 p40 homodimer. 
IL-12/LPS-induced NO Production Involves IFN-T and TNF-c~.
IL-I2-induced NO Synthesis Involves NK and T Cells.
To determine the cell types involved in the enhanced NO synthesis, cell-depletion experiments were carried out in vitro using cytolytic antibodies and complement. Depletion of Thyl.2 + cells partially reduced NO production, whereas depletion of NK cells almost completely abrogated the production of NO by peritoneal cells from MRL/Ipr mice stimulated with IL-12 and LPS (Fig. 7) . Depletion of CD4 + or CD8 + cells alone had only a modest effect. Since some NK cells also express CD8 and Thyl.2 antigens (25), it is likely that IL-12-induced NO synthesis involves mainly NK cells in addition to the adherent population.
Evidence for the Enhanced IL-12 Synthesis in MRL/Ipr Mice In Vivo.
To confirm the in vitro observations of enhanced IL-12 activity in the lupus model, experiments were carried out to measure serum levels of IL-12, IFN-% and TNF-ot in mice of different age and compared with those of sexand age-matched MRL/+ and BALB/c control mice. Fig. 8 shows that serum IL-12 levels were markedly higher in the Ipr mice, especially in the old mice with clinical disease compared with controls (12-fold in 5-8-too-old mice). This was in parallel with the elevated levels of nitrite/nitrate in the serum (Fig. 1 a) . Treatment of young (1-2-too-old) mice with LPS for as little as 2 h resulted in significantly higher serum IL-12 levels in MRL/Ipr mice compared with similarly treated control MRL/+ mice (Fig. 8 c) . Serum IFN-~/ and TNF-a were found to be low, variable, and comparable (data not shown).
rlL-12 Accelerates Autoimmune Disease in MRL/lpr Mice.
To investigate directly the role oflL-12 in the induction of autoimmune disease, young (3-wk-old) MRL/Ipr mice were given daily intraperitoneal injections of rlL-12 (300 ng/ mouse/day) or a similar volume of PBS for 9 wk. Mice were then killed and the histopathology of the kidney examined. Gross morphology of the kidneys from the IL-12-treated mice had a pale waxy surface and were firmer on sectioning, whereas those from the control PBS-injected mice appeared normal. Histological examination revealed enlarged glomeruli with significant glomerular and mesangial hypercellularity in the IL-12-treated group. In particular, most of the IL-12-treated group showed severe damage to the glomeruli, with thickening of the Bowman's capsule basement membrane and tuft-to-capsule adhesions and protein casts (Fig. 9 c) which were largely absent or scanty in the PBS-treated group (Fig. 9 a) . In contrast, pyelonephritis with extensive vasculitis and infiltration of mononuclear cells at the kidney medullary region (Fig. 9 b) was promi-nent in all the mice in the PBS-treated group. These changes were minimal in the IL-12-treated mice (Fig. 9 d) . Spleen cells from the rlL-12-treated mice showed a significantly higher percentage ofCD3 § (51.5 vs 44.5%, P = 0.02, n = 5), CD8 + (9.2 vs 5.3%, P = 0.02) and double negative (22.6 vs 17.3%, P = 0.02) T cells than those from untreated mice. There was, however, no significant difference in the spleen weight or the percentage of CD4 + T cells in the spleen cell populations between the two groups. There was also no significant difference in the anti-ss or ds DNA antibody (total antibody as well as IgM and IgG isotype) concentrations in the serum between treated and untreated mice (data not shown). However, serum IFN-3J (16.5 -+ 3.8 vs 5.2 + 1.4 pg/ml, P = 0.0189) and nitrite/ nitrate (54.2 + 2.6 vs 29.6 -3.0 IxM, P = 0.0304) were elevated in the IL-12-treated mice compared with those of PBS-treated mice. Control mice were sex-and age-matched MR, L/+ or BALB/c mice. For the LPS treatment, a total of six groups of mice (four per group) were injected (i.v. tail vein) with 50 or 500 ng per mouse of LPS in 0,1 ml PBS or PBS alone as indicated. Serum samples were collected 2 h after the treatment and IL-12 levels were determined. All samples were assayed individually by ELISA; the statistical significance of differences between lupus and the control strains of the same age groups is indicated (*P <0.05). These results suggest a causal relationship between enhanced capacity to produce IL-12 and the spontaneous autoimmune disease in this model of SLE as depicted schematically in Fig. 10 . An earlier report (5) demonstrated that N O is a critical mediator of the autoimmune disease in MRL/ lpr mice. It has also been documented that many autoimmune animal models including the lupus M R L strain of mice do not develop autoimmune disease when kept in a germ-free environment (26, 27) , consistent with our finding that LPS and IFN-~/ are required for the activation of macrophages to produce high concentrations of N O and IL-12, which is produced by monocyte/macrophages (28) . It is therefore hkely that an additional factor(s) produced by IL-12-activated N K or T cells is required to synergize with IFN-~/for the production of high concentrations of N O . N K cell activity is known to be altered in MILL/lpr mice. However, this was based on their lytic activity rather than their activity to produce IFN-% IL-12 is essential for the differentiation of the T h l subset o f t cells (32) (33) (34) . It is also a powerful adjuvant for the induction of protective immunity against diseases such as cutaneous leishmaniasis (35) in which T h l cells are the main protective mechanism (for reviews see references 36, 37). Our results indicate that excessive production of IL-12 or the administration ofrlL-12 can cause autoimmune disease in susceptible mice, demonstrating the negative side of the therapeutic use of IL-12. This is consistent with a number of recent reports showing that administration of IL-12 induced: (a) earlier onset of insulin-dependent diabetes mellitus in female N O D mice (38) ; (b) more severe and prolonged disease in adoptively transferred experimental allergic encephalomyelitis (39); and (c) destructive collagen-induced arthritis (40) . Our study here demonstrates that the pathogenic effect oflL-12 in the lupus model is likely to be due to the increased production of NO. This finding not only advances our knowledge of the pathogenesis of this lupus model (and by extension to SLE), it also suggests two potential means of therapeutic intervention of the progression of this disease: neutralization of IL-12 or inhibition of iNOS.
Glomerulonephritis is a severe complication of the renal involvement which is the major cause of pathology and death in SLE (18, 41) . Although it is generally believed that the renal pathology is due to autoantibody production, immune complex deposition and complement activation, slow infections have been shown to play an important role in triggering these autoimmune responses in many models of autoimmune disorders (26) . We observed here that IL-12-treated mice had clearly reduced pyelonephritis which is known to be commonly induced by infections (42) . Our results suggest that IL-12 might have strengthened the host's defense against infection in these mice which are otherwise immunodeficient (43) (44) (45) . Thus, treatment of the autoimmune disease aiming at neutralization of IL-12 may weaken the host immune response, leading to uncontrolled infection. These results therefore demonstrated that IL-12 is beneficial in controlling infections. However, excessive production of lL-12, as in the lupus mice, will lead to severe immunopathology.
MRL/Ipr mice differ from the MRL/+ mice in the impairment of transcription of the gene encoding Fas antigen by insertion of a transposable element into the second intron of the gene (46) . However, Ipr is not a null mutation and the inhibition of Fas expression is incomplete (47) . The relationship between the impaired fas gene expression and enhanced IL-12 and NO production by the MRL/Ipr mice is at present unclear, but amenable to experimental investigation.
